Another study has suggested that rates of cerebral venous sinus thrombosis (CVST) are much higher among patients with COVID-19 than after vaccination with either the AstraZeneca or J&J vaccines.
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Randomized trial shows better outcomes for patients with acute coronary syndromes
Patient acceptance could be an advantage, researchers say
IVUS-DCB is now the second trial to support intravascular imaging in peripheral interventions—what will it take to increase its use?
Patients went home with self-testing devices plus remote access to a cardiologist—readmissions, events, and symptoms improved.
Contact: Nicole Napoli , nnapoli@acc.org, 202-669-1465 People who have had a heart attack or who are at risk for a heart attack and who stopped…
MONDAY, April 15, 2024 (HealthDay News) — You know exercise is great for your cardiovascular health, but new research suggests that your brain has a…
Contact: Nicole Napoli, 202-669-1465, nnapoli@acc.org A new system that uses dehydrated alcohol to deactivate certain nerves surrounding the kidneys’ arteri es in order to control…
Researchers sought to determine post-transplant outcomes after use of an extracorporeal perfusion system in ECD hearts donated after brain death.
A novel approach to renal denervation led to improvements in ambulatory BP, but not office-based, in this sham-controlled trial.
